HK1117826A1 - Benzimidazole compound - Google Patents

Benzimidazole compound

Info

Publication number
HK1117826A1
HK1117826A1 HK08107942.6A HK08107942A HK1117826A1 HK 1117826 A1 HK1117826 A1 HK 1117826A1 HK 08107942 A HK08107942 A HK 08107942A HK 1117826 A1 HK1117826 A1 HK 1117826A1
Authority
HK
Hong Kong
Prior art keywords
benzimidazole compound
benzimidazole
compound
Prior art date
Application number
HK08107942.6A
Other languages
English (en)
Inventor
Shuhei Miyazawa
Masanobu Shinoda
Tetsuya Kawahara
Nobuhisa Watanabe
Hitoshi Harada
Daisuke Iida
Hiroki Terauchi
Junichi Nagakawa
Hideaki Fujisaki
Atsuhiko Kubota
Masato Ueda
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of HK1117826A1 publication Critical patent/HK1117826A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK08107942.6A 2005-04-15 2008-07-17 Benzimidazole compound HK1117826A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005117643 2005-04-15
US67584805P 2005-04-29 2005-04-29
PCT/JP2006/308069 WO2006112442A1 (ja) 2005-04-15 2006-04-17 ベンズイミダゾール化合物

Publications (1)

Publication Number Publication Date
HK1117826A1 true HK1117826A1 (en) 2009-01-23

Family

ID=37115157

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08107942.6A HK1117826A1 (en) 2005-04-15 2008-07-17 Benzimidazole compound

Country Status (23)

Country Link
US (3) US20070015782A1 (el)
EP (1) EP1870409B1 (el)
JP (1) JP4949246B2 (el)
KR (1) KR101285696B1 (el)
AU (1) AU2006237974B2 (el)
BR (1) BRPI0608400B8 (el)
CA (1) CA2602610C (el)
CY (1) CY1110074T1 (el)
DE (1) DE602006014261D1 (el)
DK (1) DK1870409T3 (el)
ES (1) ES2344467T3 (el)
HK (1) HK1117826A1 (el)
HR (1) HRP20100389T1 (el)
IL (1) IL186282A (el)
ME (1) ME01855B (el)
NO (1) NO339502B1 (el)
NZ (1) NZ561920A (el)
PL (1) PL1870409T3 (el)
PT (1) PT1870409E (el)
RS (1) RS51389B (el)
RU (1) RU2409573C2 (el)
SI (1) SI1870409T1 (el)
WO (1) WO2006112442A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
JP2009196894A (ja) * 2006-10-13 2009-09-03 Eisai R & D Management Co Ltd スルフィニルベンズイミダゾール化合物またはその塩の製造方法
WO2008047681A1 (fr) * 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
TWI546306B (zh) * 2007-04-11 2016-08-21 第一三共股份有限公司 神經胺酸衍生物之製造方法
PT2071986E (pt) * 2007-12-18 2012-04-13 Nestec Sa Sistema para preparação de uma bebida a partir de ingredientes suportado por uma inserção codificada
EP2588467A1 (en) 2010-07-01 2013-05-08 Amgen Inc. Heterocyclic compounds and their use as inhibitors of pi3k activity
SI2894151T1 (sl) 2012-09-04 2021-01-29 Shanghai Hengrui Pharmaceutical Co. Ltd. Imidazolinski derivati, postopki za njihovo pripravo in njihove uporabe v medicini
EP2803666B1 (de) 2013-05-17 2016-04-27 Symrise AG Cyclische Acetale und Ketale sowie deren Verwendung als Riechstoff
JP6377334B2 (ja) * 2013-10-25 2018-08-22 東洋鋼鈑株式会社 非線形光学色素、フォトリフラクティブ材料組成物、フォトリフラクティブ基材およびホログラム記録媒体
WO2016104668A1 (ja) * 2014-12-26 2016-06-30 国立大学法人 東京大学 光学活性のプロトンポンプ阻害化合物の製造方法
US10544113B2 (en) 2016-03-07 2020-01-28 National Health Research Institute Thiazolidinone compounds and use thereof
CN112457175B (zh) * 2020-11-03 2022-09-02 山东师范大学 一种制备1,3-二苄氧基-2-丙酮的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
DE3579436D1 (de) 1984-12-18 1990-10-04 Otsuka Pharma Co Ltd Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen.
JPS62277322A (ja) 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
JPS62207271A (ja) 1986-03-06 1987-09-11 Yamanouchi Pharmaceut Co Ltd ２−ピリジルメチルチオ基または２−ピリジルメチルスルフイニル基で置換された縮合環化合物
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
JPH0643426B2 (ja) 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
JPH0222273A (ja) * 1987-07-21 1990-01-25 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物およびその医薬用途
JPH0633261B2 (ja) 1988-01-22 1994-05-02 東京田辺製薬株式会社 新規なイミダゾ［４，５−ｂピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
JP2820829B2 (ja) 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH05117268A (ja) * 1991-10-22 1993-05-14 Yoshitomi Pharmaceut Ind Ltd ピリジン化合物
JPH05177268A (ja) 1992-01-09 1993-07-20 Amada Co Ltd 縦型パンチプレス
KR20010034770A (ko) 1998-04-17 2001-04-25 우에하라 아끼라 멀티플 유닛 타입 서방성 정제
HUP0103464A3 (en) 1998-08-10 2002-11-28 U S Government Represented By Prodrugs of proton pump inhibitors and pharmaceutical compositions containing them
TW404832B (en) 1999-01-27 2000-09-11 Nang Kuang Pharmaceutical Co L The oral medicine with good stability cotaining the omeprazole or the analogues
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
EP1154771A4 (en) 1999-02-26 2005-04-20 Nitromed Inc INHIBITORS OF THE PROTON NITROSIS AND NITROSYL PUMP, COMPOSITIONS AND METHODS OF USE
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
CN100562317C (zh) 2001-10-17 2009-11-25 武田药品工业株式会社 含大量酸不稳定药物的颗粒
JP4331930B2 (ja) 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
JP2003137771A (ja) 2001-10-30 2003-05-14 Nichiko Pharmaceutical Co Ltd 難溶性薬物用医薬製剤
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004066924A2 (en) 2003-01-24 2004-08-12 Andrx Labs Llc Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
CA2518780C (en) 2003-03-12 2014-05-13 Takeda Pharmaceutical Company Limited Drug composition having active ingredient adhered at high concentration to spherical core
WO2005011637A1 (ja) 2003-08-04 2005-02-10 Eisai Co., Ltd. 用時分散型製剤
US20070015782A1 (en) * 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound

Also Published As

Publication number Publication date
KR20070120531A (ko) 2007-12-24
NO20075904L (no) 2007-11-15
CY1110074T1 (el) 2015-01-14
IL186282A0 (en) 2008-01-20
AU2006237974A1 (en) 2006-10-26
US20070010542A1 (en) 2007-01-11
US7425634B2 (en) 2008-09-16
EP1870409B1 (en) 2010-05-12
BRPI0608400A2 (pt) 2010-11-16
HRP20100389T1 (hr) 2010-08-31
EP1870409A1 (en) 2007-12-26
NO339502B1 (no) 2016-12-19
AU2006237974B2 (en) 2011-07-07
PL1870409T3 (pl) 2010-10-29
WO2006112442A1 (ja) 2006-10-26
BRPI0608400B8 (pt) 2021-05-25
US20070015782A1 (en) 2007-01-18
RS51389B (en) 2011-02-28
CA2602610A1 (en) 2006-10-26
NZ561920A (en) 2010-01-29
KR101285696B1 (ko) 2013-07-12
PT1870409E (pt) 2010-06-22
RU2409573C2 (ru) 2011-01-20
JP4949246B2 (ja) 2012-06-06
ME01855B (me) 2011-02-28
EP1870409A4 (en) 2009-09-23
IL186282A (en) 2014-05-28
DE602006014261D1 (en) 2010-06-24
SI1870409T1 (sl) 2010-08-31
US20090203911A1 (en) 2009-08-13
BRPI0608400B1 (pt) 2020-05-05
JPWO2006112442A1 (ja) 2008-12-11
DK1870409T3 (da) 2010-08-09
RU2007138053A (ru) 2009-05-20
ES2344467T3 (es) 2010-08-27
US8124780B2 (en) 2012-02-28
CA2602610C (en) 2013-01-22

Similar Documents

Publication Publication Date Title
GB0500492D0 (en) Compound
GB0513702D0 (en) Compound
GB0506133D0 (en) Compound
EP1876179A4 (en) THIENOPYRIMIDONVERBINDUNGEN
GB0520955D0 (en) Compound
SI1919907T1 (sl) Heterocikliäśna spojina
ZA200709051B (en) Heterocyclic compound
EP2011788A4 (en) OXADIAZOLIDINDIONVERBINDUNG
EP1905769A4 (en) BENZIMIDAZOLE DERIVATIVE WITH HETEROCYCLE SUBSTITUTION
HK1117826A1 (en) Benzimidazole compound
EP1985620A4 (en) COMPOUND 10a-AZALIDE
IL189897A0 (en) Benzimidazole thiophene compounds
EP2088861A4 (en) BENZIMIDAZOLE COMPOUNDS
EP2000469A4 (en) ACYLAMINOPIPERIDINVERBINDUNG
HK1110857A1 (en) Heterocyclylamide-substituted imidazoles
EP1778674A4 (en) NEW BENZIMIDAZOLE COMPOUND
GB0525323D0 (en) Compound
GB0607096D0 (en) Compound
GB0509829D0 (en) Compound
ZA200800142B (en) Heterocyclic compound
GB0604142D0 (en) Compound
ZA200708803B (en) Benzimidazole compound
GB0616173D0 (en) Compound
IL223313A (en) Benzimidazoles
GB0524685D0 (en) Compound

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190415